Greenhouse Funds Lllp Castle Biosciences Inc Transaction History

Greenhouse Funds Lllp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$11.66 - $26.0 $4.01 Million - $8.93 Million	-343,571 Reduced 69.51%	150,670 $2.07 Million
Q4 2022 Feb 14, 2023	BUY	$18.08 - $30.0 $922,152 - $1.53 Million	51,004 Added 11.51%	494,241 $11.6 Million
Q3 2022 Nov 14, 2022	BUY	$22.51 - $34.32 $138,413 - $211,033	6,149 Added 1.41%	443,237 $11.6 Million
Q2 2022 Aug 15, 2022	BUY	$16.0 - $45.99 $6.99 Million - $20.1 Million	437,088 New	437,088 $9.59 Million

162

25.3M

82.2K

150K

Ticker CSTL
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 26,297,000
Market Cap $559M
Description
Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...

Get notified when there are updates to the investment portfolio of Greenhouse Funds Lllp, based on Form 13F filings with the SEC.

Stay updated on Greenhouse Funds Lllp with notifications on news.